vs
STANDARD BIOTOOLS INC.（LAB）与First Western Financial Inc（MYFW）财务数据对比。点击上方公司名可切换其他公司
First Western Financial Inc的季度营收约是STANDARD BIOTOOLS INC.的1.4倍（$27.5M vs $19.6M），过去两年First Western Financial Inc的营收复合增速更高（10.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
第一西部金融公司是一家美国金融服务企业，总部位于科罗拉多州丹佛市，在金融服务领域开展相关业务运营。
LAB vs MYFW — 直观对比
营收规模更大
MYFW
是对方的1.4倍
$19.6M
两年增速更快
MYFW
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $27.5M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | — |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABMYFW
| Q1 26 | — | $27.5M | ||
| Q4 25 | — | $26.7M | ||
| Q3 25 | $19.6M | $26.3M | ||
| Q2 25 | $21.8M | $24.2M | ||
| Q1 25 | $40.8M | $24.8M | ||
| Q4 24 | — | $24.3M | ||
| Q3 24 | $22.1M | $22.5M | ||
| Q2 24 | $22.5M | $22.8M |
净利润LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | $3.3M | ||
| Q3 25 | $-34.7M | $3.2M | ||
| Q2 25 | $-33.5M | $2.5M | ||
| Q1 25 | $-26.0M | $4.2M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-26.9M | $2.1M | ||
| Q2 24 | $-45.7M | $1.1M |
毛利率LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — |
营业利润率LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | 16.6% | ||
| Q3 25 | -168.5% | 15.1% | ||
| Q2 25 | -118.1% | 13.7% | ||
| Q1 25 | -80.8% | 21.6% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | -120.9% | 11.9% | ||
| Q2 24 | -134.5% | 6.2% |
净利率LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | 12.9% | ||
| Q3 25 | -177.4% | 12.1% | ||
| Q2 25 | -153.7% | 10.3% | ||
| Q1 25 | -63.8% | 16.9% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | -122.0% | 9.5% | ||
| Q2 24 | -203.3% | 4.7% |
每股收益（稀释后）LABMYFW
| Q1 26 | — | $0.63 | ||
| Q4 25 | — | $0.33 | ||
| Q3 25 | $-0.09 | $0.32 | ||
| Q2 25 | $-0.09 | $0.26 | ||
| Q1 25 | $-0.07 | $0.43 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | $-0.07 | $0.22 | ||
| Q2 24 | $-0.12 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $273.4M |
| 总资产 | $539.6M | $3.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — |
总债务LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — |
股东权益LABMYFW
| Q1 26 | — | $273.4M | ||
| Q4 25 | — | $265.6M | ||
| Q3 25 | $399.7M | $261.5M | ||
| Q2 25 | $424.5M | $258.8M | ||
| Q1 25 | $454.6M | $256.6M | ||
| Q4 24 | — | $252.3M | ||
| Q3 24 | $489.3M | $248.8M | ||
| Q2 24 | $510.3M | $246.9M |
总资产LABMYFW
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | $539.6M | $3.2B | ||
| Q2 25 | $557.0M | $3.0B | ||
| Q1 25 | $579.6M | $2.9B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | $681.5M | $2.9B | ||
| Q2 24 | $708.7M | $2.9B |
负债/权益比LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-22.2M | $10.0M | ||
| Q2 25 | $-20.7M | $-9.1M | ||
| Q1 25 | $-30.3M | $8.0M | ||
| Q4 24 | — | $606.0K | ||
| Q3 24 | $-27.9M | $18.8M | ||
| Q2 24 | $-39.0M | $-11.5M |
自由现金流LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | $-5.8M | ||
| Q3 25 | $-23.1M | $9.0M | ||
| Q2 25 | $-22.6M | $-9.7M | ||
| Q1 25 | $-35.3M | $7.0M | ||
| Q4 24 | — | $-607.0K | ||
| Q3 24 | $-30.1M | $18.6M | ||
| Q2 24 | $-41.0M | $-11.9M |
自由现金流率LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | -21.6% | ||
| Q3 25 | -118.1% | 34.1% | ||
| Q2 25 | -103.6% | -39.9% | ||
| Q1 25 | -86.6% | 28.1% | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | -136.4% | 82.3% | ||
| Q2 24 | -182.2% | -52.1% |
资本支出强度LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | 14.9% | ||
| Q3 25 | 4.5% | 4.1% | ||
| Q2 25 | 8.7% | 2.4% | ||
| Q1 25 | 12.4% | 4.2% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | 10.2% | 1.3% | ||
| Q2 24 | 8.6% | 1.6% |
现金转化率LABMYFW
| Q1 26 | — | — | ||
| Q4 25 | — | -0.54× | ||
| Q3 25 | — | 3.15× | ||
| Q2 25 | — | -3.63× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 8.83× | ||
| Q2 24 | — | -10.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
MYFW
| Net Interest Income | $20.9M | 76% |
| Noninterest Income | $6.7M | 24% |
